GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Interest Coverage

CBLL (CeriBell) Interest Coverage : 0 (At Loss) (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CeriBell Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. CeriBell's Operating Income for the three months ended in Dec. 2024 was $-12.88 Mil. CeriBell's Interest Expense for the three months ended in Dec. 2024 was $-0.50 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for CeriBell's Interest Coverage or its related term are showing as below:


CBLL's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 16.84
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


CeriBell Interest Coverage Historical Data

The historical data trend for CeriBell's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CeriBell Interest Coverage Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24
Interest Coverage
- - -

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Interest Coverage Get a 7-Day Free Trial - - N/A - -

Competitive Comparison of CeriBell's Interest Coverage

For the Medical Devices subindustry, CeriBell's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CeriBell's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CeriBell's Interest Coverage distribution charts can be found below:

* The bar in red indicates where CeriBell's Interest Coverage falls into.


;
;

CeriBell Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CeriBell's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, CeriBell's Interest Expense was $-1.99 Mil. Its Operating Income was $-39.71 Mil. And its Long-Term Debt & Capital Lease Obligation was $20.87 Mil.

CeriBell did not have earnings to cover the interest expense.

CeriBell's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the three months ended in Dec. 2024, CeriBell's Interest Expense was $-0.50 Mil. Its Operating Income was $-12.88 Mil. And its Long-Term Debt & Capital Lease Obligation was $20.87 Mil.

CeriBell did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


CeriBell  (NAS:CBLL) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


CeriBell Interest Coverage Related Terms

Thank you for viewing the detailed overview of CeriBell's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


CeriBell Business Description

Traded in Other Exchanges
N/A
Address
360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.